Anelise Dentzien Pinzon , Taís Sica da Rocha , Cláudia Ricachinevsky , Jefferson Pedro Piva , Gilberto Friedman
{"title":"High-frequency oscillatory ventilation in children with acute respiratory distress syndrome: experience of a pediatric intensive care unit","authors":"Anelise Dentzien Pinzon , Taís Sica da Rocha , Cláudia Ricachinevsky , Jefferson Pedro Piva , Gilberto Friedman","doi":"10.1016/S2255-4823(13)70489-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To describe the effects of high-frequency oscillatory ventilation (HFOV) as a rescue ventilatory support in pediatric patients with acute respiratory distress syndrome (ARDS).</p></div><div><h3>Methods</h3><p>Twenty-five children (1 month < age < 17 years) admitted to a university hospital pediatric intensive care unit (ICU) with ARDS and submitted to HFOV for a minimum of 48 hours after failure of conventional mechanical ventilation were assessed.</p></div><div><h3>Results</h3><p>28 days after the onset of ARDS, the mortality rate was 52% (13/25). Over the course of 48 hours, the use of HFOV reduced the oxygenation index [38 (31–50) vs. 17 (10 - 27)] and increased the ratio of partial arterial pressure O<sub>2</sub> and fraction of inspired O<sub>2</sub> [65 [44–80) vs. 152 (106–213)]. Arterial CO<sub>2</sub> partial pressure [54 (45–74) vs. 48 (39–58)<!--> <!-->mmHg] remained unchanged. The mean airway pressure ranged between 23 and 29<!--> <!-->cmH<sub>2</sub>O. HFOV did not compromise hemodynamics, and a reduction in heart rate was observed (141<!--> <!-->±<!--> <!-->32 vs. 119<!--> <!-->±<!--> <!-->22 beats/min), whereas mean arterial pressure (66<!--> <!-->±<!--> <!-->20 vs. 71<!--> <!-->±<!--> <!-->17<!--> <!-->mmHg) and inotropic score [44 (17–130) vs. 20 (16–75)] remained stable during this period. No survivors were dependent on oxygen.</p></div><div><h3>Conclusion</h3><p>HFOV improves oxygenation in pediatric patients with ARDS and severe hypoxemia refractory to conventional ventilatory support.</p></div>","PeriodicalId":101100,"journal":{"name":"Revista da Associa??o Médica Brasileira (English Edition)","volume":"59 4","pages":"Pages 368-374"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2255-4823(13)70489-2","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista da Associa??o Médica Brasileira (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2255482313704892","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To describe the effects of high-frequency oscillatory ventilation (HFOV) as a rescue ventilatory support in pediatric patients with acute respiratory distress syndrome (ARDS).
Methods
Twenty-five children (1 month < age < 17 years) admitted to a university hospital pediatric intensive care unit (ICU) with ARDS and submitted to HFOV for a minimum of 48 hours after failure of conventional mechanical ventilation were assessed.
Results
28 days after the onset of ARDS, the mortality rate was 52% (13/25). Over the course of 48 hours, the use of HFOV reduced the oxygenation index [38 (31–50) vs. 17 (10 - 27)] and increased the ratio of partial arterial pressure O2 and fraction of inspired O2 [65 [44–80) vs. 152 (106–213)]. Arterial CO2 partial pressure [54 (45–74) vs. 48 (39–58) mmHg] remained unchanged. The mean airway pressure ranged between 23 and 29 cmH2O. HFOV did not compromise hemodynamics, and a reduction in heart rate was observed (141 ± 32 vs. 119 ± 22 beats/min), whereas mean arterial pressure (66 ± 20 vs. 71 ± 17 mmHg) and inotropic score [44 (17–130) vs. 20 (16–75)] remained stable during this period. No survivors were dependent on oxygen.
Conclusion
HFOV improves oxygenation in pediatric patients with ARDS and severe hypoxemia refractory to conventional ventilatory support.